Clinical outcomes of artificial liver support treatments for critically ill patients with liver failure
Not Applicable
Recruiting
- Conditions
- iver failureAcute liver failureAcute on chronic liver failureHepatic encephalopathyCoagulopathyHyperbilirubinemiaHyperammoniaUremiaLiver failureAcute liver failureAcute on chronic liver failureArtificial liver supportExtracorporeal liver support devicesPlasma exchangeDouble plasma molecular adsorption system
- Registration Number
- TCTR20210924003
- Lead Sponsor
- Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
1. Age > 18 years
2. Admitted to ICU
3. Diagnosed with liver failure as
3.1 Acute liver failure (ALF) as EASL 20171 and determined using King s College criteria or
3.2 Acute on chronic liver failure (ACLF) as APASL 20195 with MELD score at least 30 or AARC score higher or equal to 8
Exclusion Criteria
1. Poor prognostic coexisting disease (e.g. advanced malignancy)
2. Uncontrolled bleeding or infections
3. Uncontrolled hemodynamics instability
4. HIV infection
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method